The pharmaceutical giant Pfizer has begun testing a new coronavirus vaccine in the United States. The initial trial will involve 360 volunteers, and the first subjects have already received injections.
The vaccine was developed in a partnership between Pfizer and the German biotech company BioNTech. In addition to the U.S. trials, there will be some 200 patients enrolled in trials in Germany. Continue reading.